New Spravato FDA Approval Opens The Door to New Patients, Says Sandhya Prashad, M.D.
A new indication of Janssen’s ketamine based-nasal spray Spravato (intranasal esketamine) has been approved for rapid reduction of depression symptoms ...
A new indication of Janssen’s ketamine based-nasal spray Spravato (intranasal esketamine) has been approved for rapid reduction of depression symptoms ...
The American Society of Ketamine Physicians (ASKP) was formed in 2016 after the original founders met at the KRIYA conference ...
© 2024 Ketamine News